Drug Shortage Report for LUVOX
Report ID | 130580 |
Drug Identification Number | 01919369 |
Brand name | LUVOX |
Common or Proper name | FLUVOXAMINE |
Company Name | BGP PHARMA ULC |
Market Status | MARKETED |
Active Ingredient(s) | FLUVOXAMINE MALEATE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 2x15 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2021-01-20 |
Actual start date | 2021-01-20 |
Estimated end date | 2021-04-13 |
Actual end date | 2021-04-12 |
Shortage status | Resolved |
Updated date | 2021-04-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-12-22 | English | Compare |
v2 | 2020-12-22 | French | Compare |
v3 | 2021-01-12 | English | Compare |
v4 | 2021-01-12 | French | Compare |
v5 | 2021-01-20 | English | Compare |
v6 | 2021-01-20 | French | Compare |
v7 | 2021-01-21 | English | Compare |
v8 | 2021-02-09 | English | Compare |
v9 | 2021-02-09 | French | Compare |
v10 | 2021-03-24 | English | Compare |
v11 | 2021-03-24 | French | Compare |
v12 | 2021-04-13 | English | Compare |
v13 | 2021-04-13 | French | Compare |
Showing 1 to 13 of 13